消息

Market reaction saw FB Financial shares decline 2.4 % after the earnings release. Over the last month, the stock has returned 3.1 %, lagging the broader market’s 4.3 % gain. Zacks has assigned a #4 (Sell) rating, reflecting concerns about the bank’s near‑term prospects despite solid quarterly performance.

全文

Efficiency improved to 52.3 % (adjusted 52 %) from 55.2 % the prior quarter, but non‑interest income fell to $25.78 million versus the $27.39 million estimate, and mortgage banking income was $11.17 million against a $13.77 million forecast. Net charge‑offs stayed at 0.1 % of average loans, consistent with estimates.

全文

Net interest income hit $149 million, surpassing analyst estimates of $148.9 million and supporting a net interest margin of 4 %, above the 3.9 % forecast. The bank’s loan portfolio grew at an 11.6 % annualized rate, while deposits increased 7.7 % annually, though deposit pricing remains intense. Management highlighted margin pressure from competit...

全文

FB Financial (NYSE:FBK) reported Q2 CY2026 results that, while growing, fell short of several analyst expectations. Revenue rose to $174.8 million, a 26.6 % year‑over‑year increase but 1.4 % below consensus estimates. Adjusted earnings per share (EPS) were $1.14, matching the Zacks consensus estimate and up from $0.88 a year earlier, though 1.2 % b...

全文

Volatility remains a factor: the stock has experienced 12 price moves exceeding 5 % in the past year, yet the recent 3.5 % afternoon surge is attributed more to analyst sentiment than a fundamental shift. Analyst optimism, driven by stronger June transaction trends, suggests that employer demand for fertility and family‑building benefits will conti...

全文

Price targets have been revisited upward by multiple firms. KeyBanc lifted its target to $35 from $30, while Truist Securities and Canaccord Genuity also upgraded their ratings to “Buy” and raised their targets. This collective optimism has pushed the share price to a new 52‑week high of $32 and a current trading level of $31.73, reflecting a 23.3 ...

全文

Progyny’s recent earnings trajectory has generated a cascade of analyst upgrades, valuation shifts, and momentum signals that are reshaping the stock’s outlook. The company’s current‑fiscal‑year EPS is projected at $2.04 on $1.38 in revenue, a 7.94 % increase in EPS and 7.01 % rise in revenue versus the prior year. For the next fiscal year, the con...

全文

On July 15 2026, CEO and President Timothy J. Donahue sold 7,500 shares for $827,175. Following the Form 4 filing, Donahue retains control of 429,355 common shares—428,570 held directly and 785 controlled indirectly—while the sale reflects a modest adjustment to his overall stake.

全文

Crown’s climate transition plan outlines a decarbonization roadmap under its Twentyby30 program, setting 2030 sustainability targets and longer‑term scope 1, 2, 3 emission reductions. Supplier collaboration and a large scope 3 reduction goal by 2050 mark a shift toward integrating climate risk into its business model. The plan’s emphasis on a new b...

全文

Emerson Electric (EMR) is navigating a mixed valuation backdrop. The broker‑derived average brokerage recommendation (ABR) sits at 1.92, rated as a Strong Buy, yet Zacks Rank has shifted to #4 (Sell) after recent earnings‑estimate revisions. The downgrade followed a 0.06 % fall in the Zacks Consensus EPS estimate, while Analyst forecasts still pr...

全文